Research

Items by Bailey, Sarah

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 33.

Casal-Dominguez, J. J., Furkert, D., Ostovar, M., Teintang, L., Clarke, M. J., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2014. Characterization of BU09059 : A novel potent selective κ-receptor antagonist. ACS Chemical Neuroscience, 5 (3), pp. 177-184.

Casal-Dominguez, J. J., Clark, M., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2013. In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor. Journal of Psychopharmacology, 27 (2), pp. 192-202.

Bailey, S., Casal-Dominguez, J. and Husbands, S. M., 2012. Antidepressant effects of novel kappa-opioid receptor antagonists in the forced swim test. Journal of Psychopharmacology, 26 (8), A16.

Bailey, S. J., Casal-Dominguez, J. J. and Husbands, S. M., 2011. Anxiolytic effects of novel kappa-opioid receptor antagonists in the elevated plus maze. Journal of Psychopharmacology, 25 (8), A76.

Bailey, S. J., Casal-Dominguez, J. J., Bradbury, F. A., Traynor, J. R. and Husbands, S. M., 2010. In vivo characterisation of 5'-amino and amidino-alkyl,naltrindole derivatives at the kappa-opioid receptor. Journal of Psychopharmacology, 24 (Supplement 3), A42.

Bailey, S. J. and McCaffery, P. J., 2010. Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. In: Ritsner, M., ed. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Netherlands: Springer, pp. 105-133.

Trent, S., Drew, C. J. G., Mitchell, P. J. and Bailey, S. J., 2009. Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in rats. European Neuropsychopharmacology, 19 (12), pp. 876-886.

O'Reilly, K. C., Shumake, J., Bailey, S. J., Gonzalez-Lima, F. and Lane, M. A., 2009. Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice. European Journal of Pharmacology, 605 (1-3), pp. 68-77.

Bailey, S. J. and McCaffery, P. J., 2009. Retinoic acid signalling in neuropsychiatric disease: possible markers and treatment agents. In: Ritsner, M. S., ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Volume III: Metabolic and Peripheral Biomarkers. Vol. 3. Netherlands: Springer, pp. 171-189.

O'Reilly, K., Bailey, S. J. and Lane, M. A., 2008. Retinoid-mediated regulation of mood: Possible cellular mechanisms. Experimental Biology and Medicine, 233 (3), pp. 251-258.

O'Reilly, K. C., Bailey, S. J. and Lane, M. A., 2007. 13-Cis-retinoic acid alters serotonin reuptake transporter levels in RN46A-B14 raphe nuclei cells. FASEB Journal, 21 (6), A1178-A1178.

O'Reilly, K. C., Trent, S., Bailey, S. J. and Lane, M. A., 2007. 13-cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Experimental Biology and Medicine, 232, pp. 1195-1203.

O'Reilly, K. C., Shumake, J., Gonzalez-Lima, F., Lane, M. A. and Bailey, S. J., 2006. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology, 31 (9), pp. 1919-1927.

Slater, C. R., Fawcett, P. R. W., Walls, T. J., Lyons, P. R., Bailey, S. J., Beeson, D., Young, C. and Gardner-Medwin, D., 2006. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain, 129, pp. 2061-2076.

Lane, M. A. and Bailey, S. J., 2005. Role of retinoid signalling in the adult brain. Progress in Neurobiology, 75, pp. 275-293.

Wood, S. J. and Toth, M., 2001. Molecular pathways of anxiety revealed by knockout mice. Molecular Neurobiology, 23 (2-3), pp. 101-119.

Wood, S. and Slater, C. R., 2001. Safety factor at the neuromuscular junction. Progress in Neurobiology, 64 (4), pp. 393-429.

Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z. and Toth, M., 2001. The 5-HT1A receptor knockout mouse and anxiety. Behavioural Pharmacology, 12 (6-7), pp. 439-450.

This list was generated on Tue May 26 22:30:13 2015 IST.